Physician profile
George E Revtyak
NPI 1902867286
$44,964.68
in general payments reported to CMS, 2019-2025
16 companies · $8,245 in 2025
The $8,245 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $2,283 · 2021: $8,481 · 2022: $267 · 2023: $129 · 2025: $8,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,758 · Travel and Lodging: $1,462 · Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,757.50 |
| Travel and Lodging | $1,462.48 |
| Food and Beverage | $153.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $35,725.29 | 2019-2022 | |
| Edwards Lifesciences Corporation | $8,244.50 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $279.24 | 2019-2021 | |
| Abiomed | $213.70 | 2020-2022 | |
| Abbott Laboratories | $140.75 | 2021-2023 | Diamondback Coronary, Mitraclip |
| Astrazeneca Pharmaceuticals Lp | $89.21 | 2019-2023 | Brilinta |
| Terumo Medical Corporation | $74.15 | 2019-2022 | |
| Medtronic Vascular, INC. | $45.37 | 2019-2020 | |
| Cardiva Medical, INC. | $36.48 | 2022 | |
| Amgen INC. | $35.41 | 2019 | |
| Medtronic, INC. | $33.84 | 2021-2022 | |
| Teleflex LLC | $14.62 | 2019 | |
| Cardinal Health 200 LLC | $13.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.90 | 2019 | |
| Penumbra, INC. | $6.52 | 2023 | Indigo System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Revtyak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.